Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Hemodialysis Stories

2013-11-13 12:26:58

DALLAS, November 13, 2013 /PRNewswire/ -- The report "Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] - Global Forecast to 2018", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and Rest of the World. Browse 147...

2013-11-09 23:01:01

Doctors at the North Shore-LIJ Health System, on Saturday, will present late-breaking data showing that an investigational drug Triferic is well tolerated and effective in treating iron deficiency in patients with chronic kidney disease undergoing dialysis. Atlanta, GA (PRWEB) November 09, 2013 Doctors at the North Shore-LIJ Health System on Saturday will present late-breaking data showing that an investigational drug Triferic is well tolerated and effective in treating iron deficiency in...

2013-11-06 16:31:41

LAWRENCE, Mass., Nov. 6, 2013 /PRNewswire/ -- NxStage Medical Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, is introducing three new products at the American Society of Nephrology (ASN) Annual Kidney Week 2013 Meeting in Atlanta, GA November 5 - 10, 2013 at booth #1129. The new offerings include the NxStage System One(TM) S, Nx2me Connected Health(TM), and the NxStage Dosing Calculator. (Logo:...

2013-11-05 08:35:33

ATLANTA, Nov. 5, 2013 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it will host its second Central Venous Pathology (CVP) Summit of the year on November 7-8, 2013 at CryoLife's training facility at its corporate headquarters in suburban Atlanta and at the St. Joseph Translational Research Institute in Atlanta, Georgia. The Company expects approximately 80 physicians and...

2013-11-01 10:42:08

Body's immune response indicates type of infection and which antibiotics to use A patient's immune response may provide better and more rapid insights into the cause, severity, and prognosis of certain bacterial infections than conventional tests, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Such an "immune fingerprint" could lead to more accurate diagnoses and more appropriate antibiotic treatment. Approximately 11% of...

2013-10-31 08:34:13

LAUSANNE, Switzerland and SINGAPORE, October 31, 2013 /PRNewswire/ -- Debiotech SA, Switzerland, and AWAK Technologies Pte Ltd., Singapore, announced today that they have entered into a partnership agreement regarding the development and manufacturing of a novel miniaturized Home Hemodialysis machine intended to serve the growing need for homecare treatment of patients suffering from end-stage renal disease. This new system will be based on Debiotech's highly miniaturized Home...

2013-10-31 00:20:39

SALT LAKE CITY, Oct. 30, 2013 /PRNewswire/ -- Vital Access Corporation today announced that on Friday, October 25(th), Dr. John Ross, MD, FACS performed live VWING Vascular Needle Guide implantation cases and Dr. William Jennings, MD, FACS presented clinical data from the pivotal U.S. SAVE study at the 2013 Controversies in Dialysis Access (CiDA) Meeting in San Francisco. As part of the CiDA conference agenda, Dr. John Ross performed three VWING implantation cases at his surgical...

2013-10-30 08:32:25

In EU5, Venofer and Sanofi's Ferrlecit/Ferlixit are the Reported Patient Share Leaders in Hemodialysis, According to a New Report from BioTrends Research Group EXTON, Pa., Oct. 30, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, while familiarity with FibroGen/Astellas/AstraZeneca's FG-4592/ASP1517 is low among surveyed nephrologists in the EU5 (France, Germany, Italy, Spain...

2013-10-23 23:28:27

Over 100 new cases filed in multidistrict litigation involving allegations of life-threatening heart problems. Resource4thePeople’s national network of attorneys continue to offer complimentary consultations to consumers responding to FDA's concerns about dialysis patients suffering heart irregularities. San Diego, CA (PRWEB) October 23, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html Resource4thePeople today announced that there has been...

2013-10-18 12:56:36

Treatment shows promise for improving artery function Receiving dialysis at home while sleeping not only improves kidney health and quality of life for people with kidney disease, it could also decrease their risk of heart disease, says new study presented at the Canadian Cardiovascular Congress. "Patients with end-stage renal disease have at least a five-fold increase in cardiovascular complications," says Dr. Christopher Overgaard, one of the study's authors and a cardiologist at the...